CVS Generic Dispensing Rate Will Rise To 44.5% After Patent Expirations
CVS' generic dispensing rate is expected to increase to as much as 44.5% as a number of branded drugs go off patent this year, CEO Tom Ryan said during a May 2 analysts teleconference.
You may also be interested in...
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
NACDS has made progress in helping pharmaceutical manufacturers recognize drug store chains' role in healthcare, National Association of Chain Drug Stores Chairman Alan Levin told the association's annual meeting April 22 in Phoenix, Ariz.
HHS plans to clarify prior consent requirements in the Health Insurance Portability and Accountability Act final privacy rule through future guidelines or modifications, the department said April 12.